Europe Platelet Rich Plasma (PRP) Market Is Expected to Foresee an Outstanding CAGR of 6.6% by 2024
September 10, 2018 at 20:46 PM EDT
Valley Cottage, NY -- (SBWIRE) -- 09/10/2018 -- The market for platelet rich plasma (PRP) Europe is expected to reach US$ 37.5 Mn in 2016, up from US$ 35.3 Mn in 2015. Adoption of platelet rich plasma in treating musculoskeletal injuries, including tennis elbow, Achilles tendinopathy, and plantar fasciitis, will continue to drive revenues. PRP therapy is also gaining traction in treating sports-related and geriatric injuries, owing to its minimally invasive procedure and quicker recovery time.
